| cilazapril | <chemical> An angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. Preliminary results also indicate its potential in the treatment of congestive heart failure. It is a prodrug that is hydrolyzed after absorption to its main metabolite cilazaprilat. Pharmacological action: angiotensin-converting enzyme inhibitors, antihypertensive agents. Chemical name: 6H-Pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, 9-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)octahydro-10-oxo-, monohydrate, (1S-(1alpha,9alpha(R*)))- (12 Dec 1998) |
|---|
Synonyms : Cilazapril Hydrate, Cilazapril Monohydrobromide, Cilazapril, (S*)-Isomer, Cilazapril, Anhydrous, Inhibace, Ro 31-2848, Ro-31-2848, Hydrate, Cilazapril, Monohydrobromide, Cilazapril, Ro 31 2848, Ro 312848, Ro312848
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
Á¦ÀÏÀÎÈ÷º£À̽ºÁ¤0.5mg - »õâ
|
Á¦ÀϾàǰ |
A04203381 | Cilazapril | Àü¹®ÀǾàǰ | ±Þ¿© |
|
Á¦ÀÏÀÎÈ÷º£À̽ºÁ¤2.5mg - »õâ
|
Á¦ÀϾàǰ |
A04203371 | Cilazapril | Àü¹®ÀǾàǰ | ±Þ¿© |
|
Á¦ÀÏÀÎÈ÷º£À̽ºÁ¤1mg - »õâ
|
Á¦ÀϾàǰ |
A04203361 | Cilazapril | Àü¹®ÀǾàǰ | ±Þ¿© |
|
½Ç¶óÇÁ¸±Á¤ - »õâ
|
°æµ¿Á¦¾à |
A17603911 | Cilazapril | Àü¹®ÀǾàǰ | ±Þ¿© |
|
ÀÎÈ÷ÇÁ¸±Á¤ - »õâ
|
¸í¹®Á¦¾à |
A31804391 | Cilazapril | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¾¾ÇÁ¸±Á¤ - »õâ
|
Çѱ¹ÆÄ¸¶ |
A12604031 | Cilazapril | Àü¹®ÀǾàǰ | ±Þ¿© |
|
½Ç¶óÀÚÇÁÁ¤ - »õâ
|
¸ÞµðÄ«ÄÚ¸®¾Æ |
A10003961 | Cilazapril | Àü¹®ÀǾàǰ | ±Þ¿© |
|
´ºÀÚÇÁ¸±Á¤ - »õâ
|
Çѱ¹À¯´Ï¿ÂÁ¦¾à |
A12202721 | Cilazapril | Àü¹®ÀǾàǰ | ±Þ¿© |
|
ÀÎÅÍÇÁ¸±Á¤ - »õâ
|
ÀÎÅ͸޵ñ |
A10803031 | Cilazapril | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¸®µà¾ÈÁ¤2.5mg - »õâ
|
¾È±¹¾àǰ |
A08504711 | Cilazapril | Àü¹®ÀǾàǰ | ±Þ¿© |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|